Vanguard Group Inc. Has $709.72 Million Holdings in Masimo Corporation $MASI

Vanguard Group Inc. grew its holdings in shares of Masimo Corporation (NASDAQ:MASI) by 3.7% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 4,810,011 shares of the medical equipment provider’s stock after buying an additional 171,876 shares during the period. Vanguard Group Inc. owned approximately 8.85% of Masimo worth $709,717,000 as of its most recent filing with the SEC.

Several other hedge funds also recently modified their holdings of MASI. Massachusetts Financial Services Co. MA boosted its stake in Masimo by 6.1% during the third quarter. Massachusetts Financial Services Co. MA now owns 2,619,960 shares of the medical equipment provider’s stock worth $386,575,000 after acquiring an additional 149,567 shares in the last quarter. State Street Corp raised its holdings in shares of Masimo by 0.7% during the second quarter. State Street Corp now owns 1,486,394 shares of the medical equipment provider’s stock valued at $250,041,000 after purchasing an additional 10,403 shares during the period. Westfield Capital Management Co. LP boosted its position in shares of Masimo by 75.9% during the 2nd quarter. Westfield Capital Management Co. LP now owns 1,181,203 shares of the medical equipment provider’s stock worth $198,702,000 after purchasing an additional 509,724 shares in the last quarter. Durable Capital Partners LP grew its stake in shares of Masimo by 3.4% in the 2nd quarter. Durable Capital Partners LP now owns 1,163,898 shares of the medical equipment provider’s stock valued at $195,791,000 after buying an additional 38,279 shares during the period. Finally, Geode Capital Management LLC grew its stake in shares of Masimo by 6.2% in the 2nd quarter. Geode Capital Management LLC now owns 896,418 shares of the medical equipment provider’s stock valued at $150,817,000 after buying an additional 52,100 shares during the period. Institutional investors own 85.96% of the company’s stock.

Masimo Trading Up 0.1%

Shares of Masimo stock opened at $175.25 on Tuesday. The company has a market capitalization of $9.41 billion, a P/E ratio of -16.63, a price-to-earnings-growth ratio of 1.77 and a beta of 1.26. The stock has a fifty day simple moving average of $139.89 and a 200 day simple moving average of $143.22. Masimo Corporation has a 12-month low of $125.94 and a 12-month high of $194.88. The company has a current ratio of 2.84, a quick ratio of 1.92 and a debt-to-equity ratio of 0.69.

Analyst Ratings Changes

Several research analysts have issued reports on the company. Piper Sandler lowered Masimo from an “overweight” rating to a “hold” rating and set a $180.00 price target on the stock. in a report on Tuesday, February 17th. Stifel Nicolaus set a $180.00 target price on Masimo in a research report on Tuesday, February 17th. Wells Fargo & Company downgraded shares of Masimo from an “overweight” rating to an “equal weight” rating and reduced their price target for the company from $190.00 to $180.00 in a research report on Wednesday, February 18th. Needham & Company LLC restated a “hold” rating on shares of Masimo in a research note on Monday, December 1st. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Masimo in a research note on Thursday, January 22nd. One equities research analyst has rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $181.17.

Masimo Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.